Dr. Emiko Olsen

Thoracic medical oncologist · IEO Milano · Italy (IT) · Oncology

Tier 2STK-0039GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: irAE management
Engagement preference: Either
Advisory boards: 1
Publications: 28
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 21 Jan 2026 (237 days ago)
Next planned contact: 23 Jul 2026 Overdue
Last 6 months vs target: 0%
0 of 1 expected engagements

Insights from this stakeholder (1)

INS-0075Comparator checkpoint monotherapy
16 Jan 2026 · Efficacy
HighClosed

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
21 Jan 2026	Congress meeting	Phone	Rachel Adeyemi	Vantrexa	Comparator checkpoint monotherapy	0	MI request	Reviewed	ENG-0019
16 Jan 2026	Scientific exchange	Virtual	Rachel Adeyemi	Vantrexa	Comparator checkpoint monotherapyElderly / ECOG 2 patients	1	—	Reviewed	ENG-0049

Timeline

21 Jan 2026
Congress meeting
Comparator checkpoint monotherapy
16 Jan 2026
Scientific exchange
Comparator checkpoint monotherapy, Elderly / ECOG 2 patients

Related stakeholders (4)

IEO Milano

Dr. Oscar Xu
Oncology pharmacist
Tier 3
Dr. Mariana Sato
General neurologist
Tier 1
Dr. Ximena Olsen
Primary care physician
Tier 2
Dr. Zoë Vogel
General neurologist
Tier 2